- 全部删除
- 您的购物车当前为空
'(Aminooxy)acetamide-Val-Cit-PAB-MMAE (MMAE 5) 是用于ADC药物-接头偶联物合成的中间体。该化合物通过与聚酰胺形成肟键,得到MMAE聚酰胺偶联物,进一步与Trastuzumab偶联,制备成ADC。'
'(Aminooxy)acetamide-Val-Cit-PAB-MMAE (MMAE 5) 是用于ADC药物-接头偶联物合成的中间体。该化合物通过与聚酰胺形成肟键,得到MMAE聚酰胺偶联物,进一步与Trastuzumab偶联,制备成ADC。'
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | 待询 | 8-10周 | |
50 mg | 待询 | 8-10周 |
(Aminooxy)acetamide-Val-Cit-PAB-MMAE 相关产品
产品描述 | (Aminooxy)acetamide-Val-Cit-PAB-MMAE (MMAE 5) serves as an intermediate for synthesizing drug-linker conjugates in antibody-drug conjugates (ADCs). This compound is first conjugated to a polyamide through oxime bond formation, resulting in an MMAE polyamide conjugate. Subsequently, the MMAE polyamide conjugate is attached to Trastuzumab to create the ADC [1]. |
分子量 | 1196.48 |
分子式 | C60H97N11O14 |
CAS No. | 2446645-88-9 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容